托弗森

Enquire Best Price to Buy Tofersen in India

About API Tofersen:

Qalsody (tofersen) is the first FDA-approved therapy developed for individuals with amyotrophic lateral sclerosis (ALS) associated with mutations in the SOD1 gene. This targeted treatment is designed to address the underlying disease process involved in neurodegeneration and its progression. Granted accelerated approval by the FDA, Qalsody demonstrated a reduction in plasma neurofilament light chain (NfL) levels, a recognized biomarker associated with neuronal damage and injury.